Similar articles

• Relationship between the direct inhibitory effect of hydralazine and propildazine on arterial smooth muscle contractility and sympathetic innervation.

  Worcel M. Worcel M. J Pharmacol Exp Ther. 1978 Nov;207(2):320-30. J Pharmacol Exp Ther. 1978. PMID: 712622 No abstract available.
• Effects of cadralazine on contractions induced by norepinephrine, serotonin, angiotensin II and K+ in rabbit aortic and renal arterial strips.

  Higashio T, Kuroda K. Higashio T, et al. Arzneimittelforschung. 1988 Mar;38(3):341-6. Arzneimittelforschung. 1988. PMID: 3382457
• A new antihypertensive compound: 3 hydrazino-6- [(2-hydroxypropyl)methylamino] pyridazine dihydrochloride (ISF 2123).

  Dorigotti L, Rolandi R, Carpi C. Dorigotti L, et al. Pharmacol Res Commun. 1976 Jun;8(3):295-308. doi: 10.1016/0031-6989(76)90019-9. Pharmacol Res Commun. 1976. PMID: 17122 No abstract available.
• Effect of hydralazine on tension and membrane potential in the rat caudal artery.

  Hermsmeyer K, Trapani A, Abel PW, Worcel M. Hermsmeyer K, et al. J Pharmacol Exp Ther. 1983 Nov;227(2):322-6. J Pharmacol Exp Ther. 1983. PMID: 6631715
• In vitro differences between human arteries and veins in their responses to hydralazine.

  Lipe S, Moulds RF. Lipe S, et al. J Pharmacol Exp Ther. 1981 Apr;217(1):204-8. J Pharmacol Exp Ther. 1981. PMID: 7205655